The relationship between obesity and mortality in patients with heart failure.
By T. Horwich, G. Fonarow, M. Hamilton, W. R. Maclellan, M. Woo, J. Tillisch. Journal of the American College of Cardiology, 2001
853 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Complementary and alternative medicine
View Paper: https://www.semanticscholar.org/paper/f5f6e6c39d7e53c27cbef8e081e7c89ac18cb6f6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Body mass index and mortality in heart failure: a meta-analysis. (2008, background): “44 High circulating serum lipoproteins have the ability to bind and detoxify lipopolysacharides, thereby potentially playing a beneficial role in HF. 44 Several limitations of this meta-analysis should be noted.”
- Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. (2009, methodology): “Reprinted, with permission, from Horwich et al. ( 31 ).”
- Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. (2004, background): “(5) studied 1,203 individuals with moderate o severe CHF ( 60% in New York Heart Association NYHA] functional class IV).”
- Cardiac remodeling in obesity. (2008, background): “While it is widely accepted that obesity increases the risk of developing heart disease, a growing number of recent reports document a statistically significant survival benefit in obese patients once they have been diagnosed with cardiovascular diseases (128, 144, 145, 200, 201, 211, 244).”
- Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. (2003, background): “Several other studies have correlated high lipoprotein levels with improved survival rates among individuals with CHF (32,33).”
- Survival advantages of obesity in dialysis patients. (2005, background): “In their cohort, obese patients who had survival advantages also had a higher prevalence of hypertension and hypercholesterolemia (Figure 3) (63).”